EP3143047
BELIMUMAB FORMULATION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
15.5.2015EP published:
20.7.2022EP application number:
15724070.6
EPO information:
European Patent Register
Max expiry date:
14.5.2035
Title in English:
BELIMUMAB FORMULATIONLanguage of the patent:
English
Timeline
Today
15.5.2015EP application
20.7.2022EP Publication
Owner
Name:
GlaxoSmithKline Intellectual Property Management LimitedAddress:
980 Great West Road, Brentford, Middlesex TW8 9GS, GB
Inventor
Name:
BLAKE-HASKINS, AngelaAddress:
Gaithersburg, Maryland 20878, US
Name:
MARSHALL, TristanAddress:
Rockville, Maryland 20850, US
Name:
O'BERRY, KristenAddress:
Gaithersburg, Maryland 20878, US
Name:
PERKINS, Melissa D.Address:
McPherson, Kansas 67460, US
Priority
Number:
201461994427 PDate:
16.5.2014Country:
US
Number:
201462093734 PDate:
18.12.2014Country:
US
Number:
201462095181 PDate:
22.12.2014Country:
US
Classification
Categories:
C07K 16/28, A61K 39/395